FDA Inspection 1159808 — Bloodworks
The FDA completed an inspection of Bloodworks on Dec 20, 2021 in Federal Way, WA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection details
- Classification
- No Action Indicated (NAI)
- End Date
- Dec 20, 2021
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Federal Way, WA (United States)